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Abstract
The corticotropin-releasing hormone (CRH) system, including CRH and urocortin (UCN), is implicated in the central control of
appetite and energy metabolism. Urocortin, a recently isolated neuropeptide closely related to CRH is involved in the central signaling
cascade that inhibits energy intake. When administered intracerebroventricularly and intra-hypothalamically, UCN potently decreases food
intake. Receptors for UCN, while widely distributed, are expressed in hypothalamic nuclei. As the hypothalamus is involved in
modulating autonomic outflow, UCN may also act as a catabolic neuropeptide to facilitate energy expenditure through sympathetic-
regulated thermogenesis. To test the hypothesis that UCN also enhances regulatory energy expenditure via the activation of the
sympathetic nervous system, we examined whole body oxygen consumption (VO ) and colonic temperature in male Wistar rats in2
response to central UCN administration. That is, the intracerebroventricular injection of 1.0 mg of UCN in male Wistar rats (n510)
significantly increased whole body oxygen consumption compared to PBS control. In addition, colonic temperature was significantly
increased (D0.760.08 8C) in UCN- vs. PBS-administered rats, which was prevented by pretreatment with the ganglionic blocker
chlorisondamine. These studies suggest that UCN acutely increased whole body oxygen consumption and body temperature via central
activation of sympathetic outflow. Ó 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction injection of UCN, however, is more potent than that of
CRH [18].
Physiological mechanisms involved in regulating food Receptors for CRH and UCN are expressed in the
intake and body weight are comprised of numerous paraventricular (CRH-R1) and ventromedial hypothalamic
neurotransmitters and a complex neural network. The nuclei (CRH-R2) [4] overlapping with the distribution of
corticotropin-releasing hormone system, including CRH UCN immunoreactivity [10]. While the CRH-R1 receptors
and UCN, is considered an integral component of this display similar affinity for UCN and CRH, the CRH-R2
circuitry. Central (intracerebroventricular and intra-hypo- receptors exhibit over a 10-fold higher affinity for UCN
thalamic) administration of CRH decreases food intake [1], than CRH [14]. The CRH-R2 form has been found to be
while antagonists against CRH increase feeding [7]. widely distributed with high levels of CRH-R2 mRNA
Urocortin, a neuropeptide closely related to CRH, sharing present in the brain, including autonomic regulatory cen-
45% sequence identity [21] also decreases food intake ters in the hypothalamus and brainstem, as well as in
when intracerebroventricularly and intra-hypothalamically peripheral tissues such as the heart, skeletal muscle, lung,
administered [12,18]. The anorectic effect of the central and intestine [4,11,20]. In addition, the CRH-R2 receptors
expressed in the ventromedial hypothalamus (VMH) acti-
vate neurons involved in appetite control, which are
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also involved in modulating autonomic outflow [19], UCN injection of 100 ng ANG II confirmed correct cannula
may also act as a catabolic neuropeptide to promote energy placement. Cannula placement was verified again by the
expenditure through sympathetic stimulation of ther- same drinking response to ANG II after the completion of
mogenesis. Interestingly, central injections of CRH also each individual experiment.
increase sympathetic nervous system activity resulting in
enhanced firing rate of nerves to brown adipose tissue,
increased whole body oxygen consumption and plasma 2.3. Experimental protocol
norepinephrine levels [1,6].
Urocortin is involved in the central signaling cascade The treatments were randomly assigned to the i.c.v.
that inhibits energy intake and the CRH-R2 receptors are cannulated rats that responded positively to ANG II. The
1
expressed in discrete hypothalamic areas involved in the treatments were 0 (PBS ) and 1.0 mg UCN injected into
modulation of the autonomic nervous system. We, there- the lateral ventricle. Each rat received one of the treat-
fore, hypothesized that UCN also enhances regulatory ments on a given day followed by 2 days of recovery.
energy expenditure via the activation of the sympathetic Food was removed from the animal cages at 09:00 h and
nervous system. To test this, we examined whole body all injections were performed 2 h after the beginning of the
oxygen consumption (VO ) and colonic temperature in light cycle (between 10:00 and 11:00 h). Animals were2
male Wistar rats in response to intracerebroventricular injected in the lateral ventricle with either 2 ml of sterile
1(i.c.v.) administration of UCN. PBS or an equal volume of rat UCN (American Peptide,
1Sunnyvale, CA) in PBS using an injector cannula (C316I,
Plastics One) attached by polyethylene tubing (PE-10) to a
25-ml glass Hamilton syringe. For each trial infusate was
2. Materials and methods delivered with a CMA/100 pump (CMA/Microdialysis) at
1.0 ml /min, after which the injector cannula was left in
2.1. Animals place for an additional 1 min to allow for diffusion away
from the injection site, before being replaced by the stylet.
Adult male Wistar rats (n510; 250–325 g) from Harlan- Measurement of colonic temperature was accomplished
Teklad (Barcelona, Spain) were individually housed in using a petroleum jelly covered YSI 400 series rectal probe
suspended metabolic cages in a temperature-controlled thermocouple thermometer (Panlab S.L., Barcelona, Spain)
room (2361 8C) on a 12:12-h light–dark schedule (lights inserted a standardized distance (6 cm) until a stable
on at 08:00 h). Unless otherwise specified, animals were temperature reading was obtained. Baseline temperature
given free access to ground rat chow (Harlan-Teklad) and was measured over 60 min prior to administration of
water at all times. All procedures were performed accord- experimental treatments and every 15 min over 120 min
ing to national and institutional guidelines of the Animal post-treatment. In order to eliminate stress-related eleva-
Care and Use Committee at the University of Navarra. tions in temperature, rats were previously habituated to the
rectal probe insertion. The ganglionic blocker, chlorison-
damine diiodide (Tocris Cookson, Bristol, UK), was
2.2. Surgery dissolved in sterile water and was given intraperitoneally
(3 mg/kg) 2 h prior to UCN administration.
The rats were anesthetized with 75 mg/kg of a ketamine Whole body oxygen consumption was measured via
HCl plus 10 mg/kg xylazine and placed in a stereotaxic indirect calorimetry. A computer-controlled open circuit
instrument (Kopf Instruments, Tujunga, CA). A 24-gauge system (Datex, Deltatrac II) was used and oxygen con-
guide cannula (316GC, Plastics One, Roanoke, VA) was sumption was measured for each rat at 1-min intervals.
implanted into the right lateral cerebroventricle and an- Rats were acclimated to the 1.5-l respiration chambers over
chored to the skull with three stainless steel machine a 7-day period (1 week after the temperature study). Prior
screws (Small Parts Inc, Miami Lakes, FL) and cranioplas- to treatment, all rats had a positive drinking response to
tic cement (Dentsply, Detrey). The stereotaxic coordinates ANG II.
used were: AP, 20.8 mm, ML, 1.2 mm with respect to
bregma, and DV, 23.5 mm from the skull surface [13]. A
31-gauge stylet (316DC, Plastics One) kept the guide 2.4. Data analysis
cannula clear when the rat was not receiving injections. A
recovery period following surgery extended 1 week before Data are shown as means6S.E.M. Statistical analyses
rats were subjected to an angiotensin II (ANG II) drinking were performed by two-way analyses of variance
test. ANG II (Sigma, St. Louis, MO) was dissolved in (ANOVA) for repeated measures. Fisher’s protected least
1
sterile phosphate buffered saline1calcium (PBS ) at a significance difference test was used for comparisons
concentration of 20 ng/ml. An increased drinking response between some specific means. A P,0.05 was taken to be
of at least 3 ml of water within 20 min following an i.c.v. statistically significant.
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Fig. 1. Effects of central UCN on body temperature in male Wistar rats (n510/group). Mean colonic temperature 30 min prior to and 1.5 h following i.c.v
administration of either 1.0 mg UCN ( ' ), PBS (j), or UCN1chlorisondamine (s). Rats were used as own controls and values are expressed as
means6S.E.M. *Denotes significant difference from PBS (P,0.05).
3. Results CRH family [21], acts as an endogenous ligand for the
CRH-R2 receptor and is implicated in the regulation of
Our results demonstrate a UCN-induced increase in feeding, energy balance, and may also be involved in the
parameters associated with energy expenditure. That is, the etiology of obesity. Central administration of UCN results
i.c.v. administration of 1.0 mg of UCN in male Wistar rats in a potent suppression of food intake in rats and is less
(n510) significantly increased colonic temperature anxiogenic than CRH [3,22]. Our present results suggest a
(D0.760.08 8C). The colonic temperature results (Fig. 1) further role for UCN in the brain as a signal to promote
are expressed as net change (i.e. difference in which regulatory energy expenditure. We demonstrated that acute
average baseline measurements were subtracted from the administrations of UCN increased whole body oxygen
post-injection measurements for each rat). While each rat consumption and body temperature, apparently as a result
served as its own control, the average baseline colonic of sympathetic activation.
temperature used for difference score calculation was While our study utilized i.c.v. injections distributing
37.860.12 8C. In addition, the UCN-induced increase in UCN throughout the brain, CRH-R2 receptors located in
colonic temperature was prevented by the pretreatment the hypothalamus, namely the ventromedial and paraven-
with the ganglionic blocker chlorisondamine. While i.p. tricular nuclei, appear to be responsible for the effects of
chlorisondamine induced an initial hypothermic response CRH and UCN on food intake and energy metabolism
(21.060.10 8C) lasting |60 min, the colonic temperature [17]. Hypothalamic levels of CRH-R2 mRNA have been
returned to a stable pre-injection baseline prior to the UCN found to change in relation to peripheral variables related
administration. to energy homeostasis (plasma leptin levels) [23], while
Whole body oxygen consumption as measured by obese animals resistant to leptin are accompanied by
indirect calorimetry (Fig. 2) was significantly increased in reduced VMH CRH-R2 mRNA levels [15].
UCN- vs. PBS-administered rats. After subtracting out the Urocortin appears to have a much higher affinity for the
increase attributed to the stress of handling / injection, this CRH-R2 receptors than does CRH [21] and centrally
enhanced expenditure averaged 35% above the baseline. administered antagonists selective for CRH-R2 (but not
CRH-R1) receptors attenuate both CRH- and UCN-in-
duced anorexia [17]. UCN reduces food intake and pro-
4. Discussion motes weight loss at concentrations that do not activate the
stress response [18]. Consistent with the focus on appetite
A complex array of molecules influences the regulation regulation, considerable evidence supports the hypothesis
of appetite and energy metabolism. Urocortin, a recently that UCN plays an important part in the regulation of
characterized 40-amino acid peptide and member of the energy balance. Exogenous UCN also increases mean
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Fig. 2. Effects of central UCN on whole body oxygen consumption in male Wistar rats (n59/group). Mean oxygen consumption 1 h prior to and 2 h
following i.c.v administration of either 1.0 mg UCN ( ' ) or PBS (j). Rats were used as own controls and values are expressed as means6S.E.M. *Denotes
significant difference from PBS (P,0.05).
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